All about COVID-19

Coronavirus | New variant does not increase reinfection risk, disease severity, deaths

Medical workers wearing protective gear treat a patient infected with the COVID-19 coronavirus at the intensive care unit of the General University Hospital on the Cristmas Eve on December 24, 2020 in Prague, Czech Republic.   | Photo Credit: Getty Images

Preliminary results from a cohort study found no statistically significant difference in hospitalisation and 28-day case fatality between cases with the new coronavirus variant (VOC 201212/01) and wild-type comparator cases. There was also no significant difference in the likelihood of reinfection between variant cases and the comparator group, says a second technical briefing report by the Public Health England.

 

The preliminary assessment of outcomes of hospitalisation and case fatality caused by the new variant was performed by using a matched cohort study. In this, 1,769 genome sequenced variant cases were matched with the same number of cases which are distinctly different from the new variant. The median age of variant cases was 36 years and 35 for the wild-type cases. Over 51% of both the variant cases wild-type comparator cases were female.

Watch | All about the new coronavirus variant in Britain
 

Fewer variant cases (16 cases) were admitted to hospital compared to wild-type comparator cases (26 cases) but the difference is not significant, the report says. For case fatality assessment, 1,340 people belonging to each group who have completed 28 days since the specimen date were compared. The study found that 12 of 1,340 (0.89%) people infected with the new variant died within 28 days compared with 10 of 1,360 (0.73%) people infected with virus not belonging to the new variant. The difference in case fatality between the two groups is “not significant”, the report says.

Reinfection studied

Scientists also studied whether the new variant caused increased reinfection rates. A possible case of reinfection was considered if a PCR test was positive before 90 days of a previous infection with SARS-COV-2 virus. While only two reinfections were caused by the new variant, there were three reinfections in the other group.

Also read: Six U.K. returnees test positive for new coronavirus variant

Variant name

Following risk assessment, the nomenclature of the new variant has been changed. While the variant was earlier called Variant Under Investigation (VOI), it is now known redesignated as Variant of Concern (VOC). As a result, the new variant, which was earlier called VUI 202012/01 on detection, has been re-designated on December 18 as VOC 202012/01.

Also read: Oxford/AstraZeneca COVID-19 vaccine should be effective against new variant: Report

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jan 23, 2021 3:17:50 AM | https://www.thehindu.com/sci-tech/science/new-coronavirus-variant-does-not-increase-reinfection-risk-disease-severity-deaths/article33445811.ece

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
You are reading
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story